Susquehanna International Group’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Buy
32,452
+21,637
+200% +$880K ﹤0.01% 7525
2025
Q4
$439K Buy
10,815
+1,952
+22% +$84.9K ﹤0.01% 9106
2025
Q3
$417K Sell
8,863
-44,291
-83% -$2.3M ﹤0.01% 9383
2025
Q2
$2.77M Buy
53,154
+5,543
+12% +$304K ﹤0.01% 5121
2025
Q1
$2.88M Buy
47,611
+17,878
+60% +$1.15M ﹤0.01% 4733
2024
Q4
$2.03M Buy
29,733
+16,730
+129% +$1.17M ﹤0.01% 5278
2024
Q3
$935K Sell
13,003
-11,541
-47% -$814K ﹤0.01% 6941
2024
Q2
$1.7M Sell
24,544
-77
-0.3% -$5.62K ﹤0.01% 5409
2024
Q1
$1.97M Buy
24,621
+5,075
+26% +$452K ﹤0.01% 5381
2023
Q4
$2.14M Buy
19,546
+14,058
+256% +$1.45M ﹤0.01% 5202
2023
Q3
$553K Sell
5,488
-4,465
-45% -$513K ﹤0.01% 7993
2023
Q2
$1.35M Sell
9,953
-8,279
-45% -$1.01M ﹤0.01% 5993
2023
Q1
$1.89M Sell
18,232
-11,438
-39% -$1.11M ﹤0.01% 5258
2022
Q4
$2.63M Buy
29,670
+20,516
+224% +$1.7M ﹤0.01% 4227
2022
Q3
$734K Buy
9,154
+6,074
+197% +$573K ﹤0.01% 7439
2022
Q2
$295K Sell
3,080
-14,593
-83% -$1.75M ﹤0.01% 9600
2022
Q1
$2.63M Sell
17,673
-2,998
-15% -$419K ﹤0.01% 4872
2021
Q4
$2.93M Buy
20,671
+13,688
+196% +$1.94M ﹤0.01% 4687
2021
Q3
$914K Sell
6,983
-6,339
-48% -$829K ﹤0.01% 7808
2021
Q2
$1.83M Buy
13,322
+1,315
+11% +$180K ﹤0.01% 6117
2021
Q1
$1.57M Sell
12,007
-1,675
-12% -$202K ﹤0.01% 6517
2020
Q4
$1.53M Sell
13,682
-5,204
-28% -$493K ﹤0.01% 5698
2020
Q3
$1.49M Buy
18,886
+10,763
+133% +$878K ﹤0.01% 5200
2020
Q2
$585K Sell
8,123
-4,776
-37% -$332K ﹤0.01% 7034
2020
Q1
$739K Buy
12,899
+3,864
+43% +$356K ﹤0.01% 6067
2019
Q4
$1.01M Sell
9,035
-10,797
-54% -$1.15M ﹤0.01% 5502
2019
Q3
$1.91M Buy
19,832
+9,389
+90% +$881K ﹤0.01% 4292
2019
Q2
$894K Buy
10,443
+4,640
+80% +$381K ﹤0.01% 5922
2019
Q1
$483K Sell
5,803
-6,708
-54% -$487K ﹤0.01% 6346
2018
Q4
$803K Buy
+12,511
New +$856K ﹤0.01% 5103
2018
Q3
Sell
-12,632
Closed -$977K 9300
2018
Q2
$925K Buy
+12,632
New +$859K ﹤0.01% 5522
2017
Q3
Sell
-7,708
Closed -$387K 8876
2017
Q2
$393K Buy
+7,708
New +$381K ﹤0.01% 7083
2017
Q1
Sell
-38,842
Closed -$1.67M 9028
2016
Q4
$1.72M Buy
+38,842
New +$1.65M ﹤0.01% 4394
2016
Q1
Sell
-11,700
Closed -$515K 9055
2015
Q4
$515K Sell
11,700
-9,100
-44% -$395K ﹤0.01% 6711
2015
Q3
$993K Sell
20,800
-3,733
-15% -$205K ﹤0.01% 5772
2015
Q2
$1.43M Buy
24,533
+19,033
+346% +$1.03M ﹤0.01% 5418
2015
Q1
$278K Sell
5,500
-790
-13% -$38.7K ﹤0.01% 8106
2014
Q4
$283K Sell
6,290
-2,450
-28% -$103K ﹤0.01% 8222
2014
Q3
$322K Sell
8,740
-9,859
-53% -$391K ﹤0.01% 7914
2014
Q2
$821K Buy
+18,599
New +$843K ﹤0.01% 6466
2014
Q1
Sell
-6,929
Closed -$294K 8928
2013
Q4
$294K Buy
+6,929
New +$263K ﹤0.01% 7606

Other funds holding CNMD

Susquehanna International Group's CNMD Position: Q1 2026 in Review

Susquehanna International Group increased its CONMED (CNMD) stake by 200% in Q1 2026, buying an estimated $880K and bringing the position to 32,452 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #7525.

Susquehanna International Group first reported a position in CNMD in Q4 2013 and has held it in 41 quarters since. The position peaked at $2.93M in Q4 2021. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Susquehanna International Group held 32,452 shares of CONMED worth $1.15M as of Q1 2026.
  • Susquehanna International Group bought 21,637 CONMED shares in Q1 2026, an estimated $880K.
  • CONMED made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7525 holding.
  • Susquehanna International Group first reported a position in CONMED in Q4 2013 and has held it in 41 quarters since.
  • Susquehanna International Group's CONMED position peaked at $2.93M in Q4 2021.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.